Rituximab Treatment for Adult Purpura Nephritis with Nephrotic Syndrome
スポンサーリンク
概要
- 論文の詳細を見る
The case of a 68-year-old woman with purpura nephritis associated with nephrotic syndrome is herein described. The patient's clinical course and the findings of a renal biopsy study revealed purpura nephritis. Following treatment with corticosteroids and intravenous cyclophosphamide accompanied by an angiotensin II type I receptor-blocker, an anti-platelet drug and an hydroxymethylglutaryl (HMG)-CoA, the proteinuria mildly decreased. Additional rituximab therapy led to a complete remission. This report describes our successful experience using rituximab to treat refractory nephrotic syndrome of purpura nephritis. Further studies are required to confirm the efficacy of rituximab as an alternative therapy for nephrotic syndrome.
著者
-
Toya Yoshiyuki
Department of Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
-
Wakui Hiromichi
Department Of Medical Science And Cardiorenal Medicine Yokohama City University Graduate School Of M
-
Kanaoka Tomohiko
Department Of Medical Science And Cardiorenal Medicine Yokohama City University Graduate School Of M
-
Oshikawa Jin
Department Of Medical Science And Cardiorenal Medicine Yokohama City University School Of Medicine
-
Hashimoto Tatsuo
Department Of Medical Science And Cardiorenal Medicine Yokohama City University School Of Medicine
-
Inayama Yoshiaki
Department Of Pathology And Laboratory Medicine Yokohama City University
-
Tamura Kouichi
Department Of Medical Science And Cardiorenal Medicine Yokohama City University Graduate School Of M
-
Nagahama Kiyotaka
Department Of Pathology Toranomon Hospital
-
Umemura Satoshi
Department Of Internal Medicine Ii Yokohama City University School Of Medicine
-
Ishiguro Hiroaki
Department Of Dermatology Kochi Medical School
-
Kobayashi Yusuke
Department Of Genome System Science Yokohama City University
-
Yoshida Shinichiro
Department Of Internal Medicine Nagasaki National Medical Center
-
Suzuki Shota
Department of Pure and Applied Chemistry, Faculty of Science and Technology, Tokyo University of Sci
-
AZUSHIMA Kengo
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
-
Tamura Kouichi
Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan
-
Yoshida Shinichiro
Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan
-
Kanaoka Tomohiko
Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan
-
Kobayashi Yusuke
Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan
-
Akata Mariko
Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan
-
Hashimoto Tatsuo
Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan
関連論文
- PJ-004 Inflammatory Markers at the Site of Culprit Coronary Plaque in Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-3 (IHD) PJ1,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese
- Early, Accurate, Non-Invasive Predictors of Left Main or 3-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
- Effects of angiotension II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- Effect of LDL Apheresis on Atherosclerosis Goes beyond Its Cholesterol Lowering in Hemodialysis Patients : A Pilot Study
- Behcet's disease complicated by IgA nephropathy with nephrotic syndrome
- OE-254 Overexpression of ATRAP(AT1 receptor-assosiated protein) in cardiomyocytes completely inhibits cardiac hypertrophy induced by Angiotensin(Cardiac hypertrophy, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- NEDD4L protein truncating variant (v13[G/A] : rs4149601) is associated with essential hypertension in a sample of the Japanese population
- PJ-685 Prognostic Value of APACHE II Score for Patients Suffering Massive Pulmonary Embolism(PJ115,Thromboembolism/Antithrombotic Therapy/Thrombolysis (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Association of SLC6A9 Gene Variants with Human Essential Hypertension